Editorial

» opinion, neuroscience and immunology

Most Recent

image: Nosing Around

Nosing Around

By | November 1, 2016

Covering neuroscience research means choosing from an embarrassment of riches.

0 Comments

image: An Evolutionary History

An Evolutionary History

By | October 1, 2016

Celebrating 30 years and a resurrection

2 Comments

image: Special Delivery

Special Delivery

By | October 1, 2015

Neurons in new brains and old

0 Comments

image: Hear and Now

Hear and Now

By | September 1, 2015

Auditory research advances worth shouting about

0 Comments

image: New Legs to Stand On

New Legs to Stand On

By | June 1, 2015

Reconstructing the past using ancient DNA

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: Cerebral Sleuths

Cerebral Sleuths

By | November 1, 2014

For neuroscientists, experimental results converge to help crack the case of how the brain functions.

0 Comments

image: Eye Spies

Eye Spies

By | October 1, 2014

An issue highlighting advances in vision research

0 Comments

image: Your Brain on Art

Your Brain on Art

By | May 1, 2014

A new scientific discipline investigates the neurology underlying the experience and the creation of beauty.

0 Comments

image: Exploring the Neuron Forest

Exploring the Neuron Forest

By | November 1, 2013

Innovations in imaging techniques and genetic sequencing take neuroscience to a new level.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham